o-desmethylvenlafaxine (odv) multiparticulate formulation, methods for treating depression in a patient in need thereof and for reducing the gastrointestinal side effects of venlafaxine in a patient, modified multiparticulate release formulation, method for reducing side effects odv in a patient, modified-release venlafaxine product, methods to reduce gastrointestinal side effects associated with venlafaxine treatment, and to release odv in a pediatric or geriatric patient, odv and / or succinate multiparticulate formulations delayed release of odv formate or succinate, use of a formulation, and pharmaceutical package

摘要

FORMULATION OF MULTIPARTICULATES OF A DEMETHYVENLAFAXINE (ODV), METHODS TO DEATURE DEPRESSION IN A PATIENT AT THEIR NEED AND TO REDUCE GASTRINTESTINAL SIDE EFFECTS IN A PATIENT, MULTI-DIFFETULATED MUSPETHYPHINE FOR PATIENTS ODV IN A PATIENT, MODIFIED RELEASE DEVICE AND MODULATED VENLAFAXIN PRODUCT, METHODS TO REDUCE GASTRINTESTINAL SIDE DOES, AND TO RELEASE ODV TO A PEDIATRIC DEDICATION OR MULTI-DEPRACED FORMULAR DEDICATION ODV FORMIAT OR SUCCINATE, USE OF A FORMULATION, AND PHARMACEUTICAL PACKAGE A multiparticulate O-desmethylvenlafaxine (ODV) succinate or formate is described. Methods of treating depression and reducing gastrointestinal side effects of ODV are also described.